To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Caprion Proteomics
News Caprion Proteomics
-
Mr. Martin LeBlanc becomes a Director of Victhom
Victhom Human Bionics Inc. announced that Mr. Martin LeBlanc had joined its Board of Directors on March 23rd, 2007. "Mr. LeBlanc will be bringing exceptional expertise to Victhom, and his experience will be especially relevant and useful for the future development of the Company" said Mr. Daniel Joh more
-
Caprion Receives FDA Fast Track Designation for Shigamabs Clinical Program
Caprion Pharmaceuticals Inc. announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to Shigamabs, its dual antibody product being developed for the treatment of Shigatoxin-producing bacterial infections. The Company anticipates moving Shigamabs into a pivotal Pha more
Market studies Caprion Proteomics
-
Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic SWOT Analysis Review
Dragon Pharmaceutical Inc. (Dragon Pharma) is a research oriented pharmaceutical company that is engaged in production and commercialization of antibiotic products. The company provides two categories of antibiotic products under two divisions namely; Cephalosporin Group and Penicillin Group. Dragon more
-
Welichem Biotech Inc. (WBI) - Financial and Strategic SWOT Analysis Review
Welichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is principally engaged in the discovery, research and development of therapeutics to treat autoimmune/inflammatory diseases and cancers. The company investigates its drug candida more
-
Transition Therapeutics Inc. (TTH) - Financial and Strategic SWOT Analysis Review
Transition Therapeutics Inc. (Transition Therapeutics) is a publicly held biopharmaceutical company. The company is engaged in the drug development program for the development of novel therapeutics in multiple disease indications. Its products primarily comprise of medicines used for the treatment o more
Websites Caprion Proteomics
Career Opportunities : Caprion
Revealing Differences in the Proteome Services Biomarker Discovery MRM Assays Custom Services Target Discovery In Vitro Diagnostics Strategy Pipeline Technology Resources Presentations White Papers Case Studies Publications About Caprion Corporate Overview Management Board of Directors Career Opport more
Our Network, Vertex Pharmaceuticals | vrtx.com
/ /our_dna_unraveled.html /a-network-of-minds.html /finances.html /current-projects.html http://investors.vrtx.com/press.cfm /Resources.html /destination-vertex.html “Great discoveries and improvements invariably involve the cooperation of many minds.” — Alexander Graham Bell Collaboration is our fo more
HUPO 2010 Sydney:: 19-23 September 2010
Confirmed speakers to date include: Ruedi Aebersold Professor, Institute of Molecular Systems Biology, Zurich, Switzerland Ruedi Aebersold is one of the pioneers in proteomics. He is known for developing methods that have found wide application in analytical protein chemistry like a new clas more
Watchlist
This is where you can add this topic to your personal favourites
